News

In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...
Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...
In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...
The stock trades at an exceptionally attractive valuation. Pfizer faces some challenges but should continue to survive and ...
Patients receiving nirmatrelvir/ritonavir experience a quicker resolution of COVID-19 symptoms and are less likely to have worsened symptoms than those receiving placebo, a recent study shows.
In separate multidistrict litigation dockets over injectible birth control Depo-Provera and toxic chemicals in drinking water, federal judges ordered plaintiffs’ lawyers to file their lawsuits after ...
Reimbursement authority NICE has backed the use of the two drugs as a first-line option for patients living with urothelial cancer (UC) – the most common form of bladder cancer – which has spread to ...
West Virginia Attorney General J.B. McCuskey has asked that two lawsuits filed in separate county circuit courts over Gov.
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
The AAP published its own vaccine schedule in a break from federal guidance. HHS secretary RFK Jr. took to social media to respond.
Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...
Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...